ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european commission evolution neuroscience

Week in Review: February 10–14
Tracy Vence | Feb 14, 2014 | 3 min read
First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism
Data protection illustration
Opinion: Is Open Access Worth the Cost?
Jingshan S. Du | Jun 1, 2022 | 6 min read
As we continue to transition out of the print era of scientific publishing, funders and institutions are paying a steep price to have trustworthy publishers certify research outcomes.
Senior Scientists Quit Europe
Silvia Sanides | Jun 1, 2003 | 7 min read
©Paul Barton, Corbis Rigid retirement policies are prompting scientists to flee Europe at the height of their professional lives to start second careers in the United States. Many of these researchers are still conducting experiments and are in no mood to slow down. But because nearly all European universities are government run, professors are left little choice when they reach mandatory retirement age, which in most countries is 65 years or even younger. Some scientists leaving for the
Your Body Is Teeming with Weed Receptors
Megan Scudellari | Jul 16, 2017 | 10+ min read
And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.
Mail
The Scientist Staff | Dec 1, 2007 | 6 min read
To frame, or not to frame? Re: "The future of public engagement,"1 the first thing scientists need to do is abandon all talk of tentativeness, paradigms, and social construct when talking to the public about science. This model of science is appropriate in certain circles, but I see not a shred of evidence that it has improved public scientific literacy, and [I see] a great deal of evidence that it has been used by charlatans to dismiss scientific findings or push bogus alternativ
Genetics-Based Testing Could Create A Biologic Underclass
Dorothy Nelkin | Nov 26, 1989 | 9 min read
[Editor’s note: Sophisticated biological tests that can uncover latent problems or predict future diseases have been developed over the past few years. Such tests have important clinical applications, but they also have found their way into nonclinical contexts in which they provide unprecedented threats to our traditional concepts of privacy and personal autonomy. So say Dorothy Nelkin and Laurence Tancredi, coauthors of a new book, Dangerous Diagnostics: The Social Power of Biological I

Run a Search

ADVERTISEMENT